Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Opioids Stories

2012-04-17 02:27:52

RALEIGH, N.C., April 17, 2012 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that the U.S. Patent and Trademark Office (USPTO) has formally awarded BDSI's patent No. 13/184306, "Transmucosal Delivery Devices with Enhanced Uptake," which extends the patent protection for BDSI's BioErodible MucoAdhesive (BEMA) products, BEMA Buprenorphine and BEMA Buprenorphine/Naloxone, by seven years to 2027. The USPTO had issued a Notice of Allowance to BDSI for...

2012-04-16 02:27:48

RALEIGH, N.C., April 16, 2012 /PRNewswire/-- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Future Leaders in the Biotech Industry Conference at the Millennium Broadway Hotel & Conference Center, New York City. The presentation is scheduled for Friday, April 20, 2012 at 3:00 P.M. Eastern Time. (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO) Dr. Sirgo will focus...

2012-04-12 23:00:48

As published on March 27th, 2012 in the Pharmaceutical Business Review, Insys Therapeutics launched Subsys (Fentanyl sublingual spray) for the management of persistent cancer pain. Fentanyl is a potent synthetic narcotic analgesic used to treat breakthrough cancer pain and is commonly used in pre-procedures as a pain reliever as well as an anesthetic. On September 2nd 2011, the widower of a New York woman, Steven Shemelia filed a lawsuit (case no. 2:2011cv05559) at the Philadelphia Court of...

2012-04-12 06:26:00

LANSING, Mich., April 12, 2012 /PRNewswire/ -- Accident Fund Holdings, Inc. (AFHI) recently created a comprehensive narcotics program to help reduce the health risks of these drugs on injured workers and ultimately provide a mechanism for them to get back to work sooner. (Logo: http://photos.prnewswire.com/prnh/20100727/DE40865LOGO ) AFHI's program incorporates data analytics, case management and peer-to-peer physician pharmaceutical review. Unique to this program is the integration of...

2012-04-12 06:24:40

LOS ANGELES, April 12, 2012 /PRNewswire/ -- The producers of "How Drugs Work" are bringing an exciting and gritty new season to a major cable network, telling the truth about the power of addiction. Drug addiction affects the body and the mind and has grave impact on an addict's family members and loved ones... This series dives deeper into the devastating effect that drugs have on the world of an addict and the medical and psychological aspects of addiction....

2012-04-12 02:38:11

REDWOOD CITY, Calif., April 12, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported dosing of the first patient in the second of three planned Phase 3 studies that will form the basis of a planned New Drug Application (NDA) for the Sufentanil NanoTab® PCA System, ARX-01. Utilizing a...

2012-04-11 02:24:34

REDWOOD CITY, Calif., April 11, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that the U.S. Patent and Trademark Office (USPTO) has issued AcelRx two Notices of Allowance for the patent applications entitled "Small-Volume Oral Transmucosal Dosage Forms" and "Bioadhesive Drug Formulations for Oral Transmucosal...

2012-04-10 14:22:32

BEDMINSTER, N.J. and SYDNEY, April 10, 2012 /PRNewswire/ -- QRxPharma (ASX: QRX and OTCQX: QRXPY) announced today successful completion of two Phase 1 studies in healthy volunteers for MoxDuo® CR, a controlled-release Dual-Opioid® utilising a 3:2 ratio of morphine and oxycodone. The proprietary MoxDuo CR formulation, encompassing both sustained delivery technology as well as abuse deterrent and tamper resistant features, is designed to provide at least 12 hours of analgesia in...

Florida In The Middle Of Pain-Killer Boom Once More
2012-04-10 04:45:22

The US Drug Enforcement Administration (DEA) is inspecting 6 Walgreens pharmacies and its Florida distribution center in response to a jump in purchases of oxycodone, a highly addictive pain killer. According to Reuters, the DEA has issued inspection warrants to Walgreen´s distribution center as well as stores in Hudson, Port Richey, Oviedo, Fort Meyers, and two stores in Fort Pierce, Florida. In accordance with the US Controlled Substance Act, warrants may be issued for “valid...

2012-04-06 02:20:49

BALTIMORE, April 6, 2012 /PRNewswire/ -- Ameritox(SM), the nation's leader in pain medication monitoring, commends Unlawful Narcotics Investigations, Treatment and Education, Inc. (Operation UNITE), the organizers of the inaugural National Rx Drug Abuse Summit, on its coordination of a national forum to address the prescription drug abuse epidemic. The Summit will be held April 10-12 in Orlando, Florida. "As the nation's leader in Pain Medication Monitoring...